ETF Holdings Breakdown of TNGX

TNGX institutional holdings

The following institutional investment holdings of TNGX have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	71,593	USD 549,118	7.67
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	71,593 0.3%	USD 549,118 -9.0%	7.67
Total =		143,186	USD 1,098,236

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with TNGX

Analysts Set Tango Therapeutics, Inc. (NASDAQ:TNGX) PT at $10.50

Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have been assigned an average recommendation of “Buy” from the five ratings firms that are currently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued a report on the […] - 2025-09-15 02:13:01

Tango Therapeutics (NASDAQ:TNGX) Shares Down 6.7% After Insider Selling

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report)’s share price was down 6.7% on Wednesday following insider selling activity. The company traded as low as $6.45 and last traded at $6.37. Approximately 361,607 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 1,719,090 shares. The stock had previously […] - 2025-09-11 02:34:45

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $10.33 Average Target Price from Analysts

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on the stock in the […] - 2025-08-21 03:01:18

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $12.20 Consensus PT from Brokerages

Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock […] - 2025-07-01 02:50:59

Bank of America Corp DE Has $841,000 Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX)

Bank of America Corp DE grew its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 55.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 272,233 shares of the company’s stock after acquiring an additional 96,864 shares during the quarter. Bank of America […] - 2025-06-09 04:16:53

Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC cut its position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 6.1% during the 4th quarter, Holdings Channel reports. The firm owned 192,259 shares of the company’s stock after selling 12,562 shares during the period. Nuveen Asset Management LLC’s holdings in Tango Therapeutics were worth $594,000 at the […] - 2025-06-06 04:54:52

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of “Buy” from Brokerages

Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report on the stock […] - 2025-06-03 02:18:55

Graham Capital Management L.P. Invests $108,000 in Tango Therapeutics, Inc. (NASDAQ:TNGX)

Graham Capital Management L.P. acquired a new position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 34,804 shares of the company’s stock, valued at approximately $108,000. Other institutional investors have also modified their holdings of the company. […] - 2025-05-20 05:10:55

Dimensional Fund Advisors LP Raises Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)

Dimensional Fund Advisors LP increased its stake in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 83.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 662,776 shares of the company’s stock after purchasing an additional 302,087 shares during the quarter. Dimensional Fund Advisors LP’s […] - 2025-05-15 04:32:48

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of “Buy” from Analysts

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has earned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the last […] - 2025-05-09 03:12:43

Brokerages Set Tango Therapeutics, Inc. (NASDAQ:TNGX) PT at $12.33

Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have been assigned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the […] - 2025-04-17 02:08:48

American Century Companies Inc. Increases Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)

American Century Companies Inc. grew its position in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 12.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 110,448 shares of the company’s stock after purchasing an additional 12,162 shares during the quarter. American Century Companies Inc.’s holdings in Tango Therapeutics were worth $341,000 as […] - 2025-04-14 04:42:49

Schroder Investment Management Group Makes New Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX)

Schroder Investment Management Group bought a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 655,158 shares of the company’s stock, valued at approximately $2,031,000. Schroder Investment Management Group owned approximately 0.61% […] - 2025-04-07 05:11:04

Los Angeles Capital Management LLC Makes New $218,000 Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX)

Los Angeles Capital Management LLC purchased a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 70,452 shares of the company’s stock, valued at approximately $218,000. Los Angeles Capital Management […] - 2025-03-05 08:41:43

Analysts Set Tango Therapeutics, Inc. (NASDAQ:TNGX) PT at $12.33

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued ratings on the stock in […] - 2025-02-26 04:22:50

Back to Listing

Disclaimer